NCT05841472 2023-08-30Anti-PD-1 Antibody Therapies of Camrelizumab in Combination With Pemetrexed and Carboplatin as First-line Treatment in Patients With Advanced or Metastatic Non-Squamous Non-Small Cell Lung CancerCrystalGenomics, Inc.Phase 2 Recruiting60 enrolled